Summary

Requires OSHA to issue employer guidance and requires federal agencies to acquire and maintain opioid overdose reversal medication and offer voluntary annual employee training on its use. The Department of Labor must publish nonmandatory guidance for private employers and binding regulations for all federal agencies within 270 days of enactment; the Postal Service is excluded from the employer guidance definition but federal agencies (including the Veterans Health Administration) are expressly required to comply with the federal-agency rule.

• OSHA must issue nonmandatory employer guidance within 270 days on acquiring/maintaining opioid overdose reversal medication and offering voluntary annual training.
• OSHA must issue binding regulations within 270 days requiring every federal agency and instrumentality to acquire and maintain overdose reversal medication and offer voluntary annual training to employees.
• The United States Postal Service is excluded from the employer definition for the nonmandatory guidance.
• The mandatory federal requirement expressly includes the Veterans Health Administration despite prior statutory language that might have limited such requirements.
• Training for employees is voluntary but must be offered annually under the federal-agency rule and described in employer guidance for private workplaces.
• No specific funding is authorized; costs for medication procurement and training would come from agency budgets or private employer resources.
• Technical details (storage, dosing, recordkeeping, certification) are left to OSHA to define in guidance and regulation.
• The guidance/regulation timeline is short (270 days), requiring prompt administrative action by OSHA and federal agencies.